Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 4 1

Status

Completed 21Terminated 9Unknown 7Withdrawn 3Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Thoracic 1Plasma cell 1

Conditions

Polycystic Ovary Syndrome 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Recurrence 1Multiple Myeloma 1Leukemia, Myeloid, Chronic-Phase 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Pioglitazone × Clear all
NCT05394142 2024-04-22

SPIOMET4HEALTH

Fundació Sant Joan de Déu

Phase 2 Unknown
364 enrolled

Polycystic Ovary Syndrome

NCT05519813 2022-08-29

Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.

Shengjing Hospital

Phase 4 Unknown
60 enrolled

Polycystic Ovary Syndrome

NCT02767063 2020-08-07

ACTIW

Versailles Hospital

Phase 1/2 Unknown
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02889003 2018-03-22

PIO2STOP

Versailles Hospital

Phase 2 Unknown
26 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02687425 2016-02-22

SESPI

Tongji Hospital

Phase 2 Unknown
20 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01010243 2012-05-30

MM03

University of Regensburg

Phase 1/2 Unknown
54 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡